Introduction
FLT PET-CT (Fluorine-18 Fluorothymidine Positron Emission Tomography – Computed Tomography) is a specialized molecular imaging technique used to evaluate tumor cell proliferation.
Unlike standard glucose-based PET scans, FLT PET-CT reflects cellular DNA synthesis activity, providing insight into how actively tumor cells are dividing.
FLT PET-CT is primarily used in oncology research and selected clinical settings to assess tumor aggressiveness and early response to cancer treatment.
It can be especially valuable when conventional imaging is insufficient to distinguish between active tumor growth and treatment-related changes.
Türkiye is a trusted destination for advanced nuclear medicine imaging, offering modern PET-CT technology, experienced specialists, and integrated oncology care.
Averia Health supports international patients through ethical, structured, and fully coordinated FLT PET-CT services focused on diagnostic precision and clinical decision support.
Why Choose Türkiye for FLT PET-CT
Türkiye is internationally recognized for high-quality advanced PET imaging because of:
- Modern PET-CT scanners with high sensitivity
- Availability of F-18 FLT radiotracers in specialized centers
- Experienced nuclear medicine physicians
- Strict radiation safety and quality assurance protocols
- Multidisciplinary collaboration with oncology teams
- Internationally accredited hospitals
Türkiye combines advanced imaging infrastructure with expert interpretation.
Why Choose Averia Health
Averia Health provides comprehensive coordination for FLT PET-CT scans:
- Pre-arrival review of medical history, diagnosis, and imaging goals
- Referral to accredited nuclear medicine centers experienced in FLT imaging
- Clear explanation of the scan’s purpose and preparation
- Coordination with oncology and treating specialists
- Professional interpreter services
- 24/7 patient support during your visit
- Timely reporting and international follow-up coordination
Our approach prioritizes transparency, ethical use of advanced imaging, and patient reassurance.
Conditions Evaluated with FLT PET-CT
FLT PET-CT may be recommended for:
- Evaluation of tumor proliferation activity
- Assessment of treatment response in selected cancers
- Differentiation between active tumor and post-treatment changes
- Research or advanced clinical evaluation of solid tumors
- Monitoring response to chemotherapy, radiotherapy, or targeted therapies
Its use is typically guided by oncology specialists and specific clinical questions.
Clinical Applications of FLT PET-CT
Tumor Proliferation Assessment
Measures cellular division activity rather than glucose metabolism.
Early Treatment Response Evaluation
Detects changes in tumor activity before structural changes appear.
Therapy Monitoring
Helps assess effectiveness of anti-proliferative cancer treatments.
Advanced Oncologic Evaluation
Used when FDG PET-CT findings are inconclusive.
FLT PET-CT complements, rather than replaces, standard oncologic imaging.
Diagnostic Evaluation Before FLT PET-CT
Preparation and evaluation may include:
- Review of prior imaging studies (FDG PET-CT, CT, MRI)
- Oncology consultation and treatment history review
- Medication review
- Fasting instructions if required by protocol
- Assessment for pregnancy or breastfeeding when applicable
Proper evaluation ensures appropriate use and accurate interpretation.
FLT PET-CT Scan Journey in Türkiye
- Pre-Arrival Case Review
Medical records and imaging indications are reviewed in advance. - Nuclear Medicine Consultation
The procedure, tracer characteristics, and expectations are explained clearly. - FLT Tracer Administration
A small amount of F-18 FLT radiotracer is administered intravenously. - PET-CT Imaging
Whole-body or targeted imaging is performed using advanced PET-CT systems. - Image Interpretation
Scans are analyzed by experienced nuclear medicine specialists. - Results & Care Coordination
Findings are shared with the treating oncology team to guide next steps.
Expected Results & Benefits
- Insight into tumor growth and proliferation
- Early assessment of treatment effectiveness
- Improved differentiation between active disease and treatment effects
- Enhanced oncologic decision-making
- Support for personalized cancer treatment planning
FLT PET-CT provides functional data that may not be visible on conventional scans.
Risks & Considerations
FLT PET-CT is safe and well established in specialized settings. Considerations include:
- Exposure to a low level of radiation
- Temporary discomfort from tracer injection
- Limited availability and indication-specific use
- Results must be interpreted alongside clinical and imaging findings
The scan is used selectively to ensure meaningful clinical benefit.
What’s Included in Your Medical Visit
- FLT PET-CT scan appointment
- Nuclear medicine consultation
- F-18 FLT tracer administration
- PET-CT imaging and expert interpretation
- Written diagnostic report
- Coordination with oncology specialists
- Interpreter services
- Patient support and follow-up coordination
Averia Health ensures ethical, precise, and patient-centered advanced imaging care.
Frequently Asked Questions
How is FLT PET-CT different from FDG PET-CT?
FLT evaluates tumor cell proliferation, while FDG measures glucose metabolism.
Is FLT PET-CT widely used?
It is used selectively in specialized oncology centers and research-based care.
Is FLT PET-CT safe?
Yes. Radiation exposure is controlled within accepted medical standards.
Can FLT PET-CT replace other imaging tests?
No. It complements standard imaging when additional functional data is needed.
How quickly will I receive the results?
Results are typically available shortly after expert interpretation.
Ready to Start Your Health Journey?
Access advanced tumor proliferation imaging with FLT PET-CT in Türkiye for precise oncologic assessment.
Request a case review or contact us on WhatsApp to speak with our diagnostic care coordination team.
